GGrantIndex
← Search

HOST PERIPHERAL BLOOD BIOMARKERS TO DIAGNOSE ACTIVE LYME DISEASE AND POST-TREATMENT LYME DISEASE SYNDROME

$754,214FY2022Defense Health AgencyDOD

The Research Foundation For The State University Of New York

Investigators

View source on USAspending →
HOST PERIPHERAL BLOOD BIOMARKERS TO DIAGNOSE ACTIVE LYME DISEASE AND POST-TREATMENT LYME DISEASE SYNDROME · GrantIndex